Return to content in this issue

 

Treatment and outcome in deficiency of adenosine deaminase 2: a literature review

Zhang B1, Xu N1, Chen J2, Zhang S3, Huang X2, Shen M4, Zeng X1

1Department of General Internal Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
2Department of General Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
3Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
4Department of Rheumatology and Clinical Immunology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China

J Investig Allergol Clin Immunol 2022; Vol. 32(1)
doi: 10.18176/jiaci.0748

Key words: Deficiency of adenosine deaminase 2, Treatment, Outcome, TNFa inhibitor

Title Type Size
doi10.18176_jiaci.0748materialsupltable.pdf pdf 713.92 Kb